Open Label Trial to Study the Long-term Safety and Efficacy of Seletracetam for the Treatment of Epilepsy

Safety and Tolerability Study of Levetiracetam to Treat Patients With Status Epilepticus

NCT00362141 ·Status: UNKNOWN ·Phase: PHASE2

An Open Label Study of L059 Intravenous (IV) in Japanese Epilepsy Subjects With Partial Onset Seizures

NCT01407523 ·Status: COMPLETED ·Phase: PHASE2

Monotherapy With Levetiracetam in Newly Diagnosed Patients Suffering From Epilepsy

NCT00150735 ·Status: COMPLETED ·Phase: PHASE3

Follow up Trial for Keppra (Levetiracetam) as Monotherapy in Patients With Newly Diagnosed Epilepsy Coming From N01175 (NCT00175903).

NCT00291655 ·Status: COMPLETED ·Phase: PHASE3

Study on the Treatment of Elderly Patients With Older and Newer Antiepileptic Drugs

NCT00438451 ·Status: COMPLETED ·Phase: PHASE4

Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset Seizures

NCT00152516 ·Status: COMPLETED ·Phase: PHASE3

A Phase IV-Pharmacovigilance Study of Keppra Greece - S.K.A.T.E.: Safety of Keppra as Adjunctive Therapy in Epilepsy

NCT00631150 ·Status: COMPLETED ·Phase: PHASE4

Long Term Follow up Treatment With Levetiracetam in Subjects of 4 Years and Older With Generalized Epilepsy

NCT00150748 ·Status: COMPLETED ·Phase: PHASE3

A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.

NCT00175890 ·Status: COMPLETED ·Phase: PHASE3

An Open Label Study of Levetiracetam Monotherapy in Patients With Newly Diagnosed Focal Epilepsy

NCT01506882 ·Status: COMPLETED ·Phase: PHASE3

Monotherapy With Levetiracetam or Carbamazepine in Patients Suffering From Epilepsy.

NCT00150787 ·Status: COMPLETED ·Phase: PHASE3

Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label Method

NCT00160615 ·Status: COMPLETED ·Phase: PHASE3

Open Label Safety and Efficacy Study of Levetiracetam in Patients With Epilepsy

NCT00160654 ·Status: COMPLETED ·Phase: PHASE4

A Study of Brivaracetam in Subjects With Partial Onset Seizures

NCT00175929 ·Status: COMPLETED ·Phase: PHASE2

Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With Epilepsy

NCT00160628 ·Status: COMPLETED ·Phase: PHASE3

A Long Term Follow up Administration Study of L059 (Levetiracetam) in Epilepsy Patients With Partial Onset Seizures

NCT00367432 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Intravenous Brivaracetam in Subjects >= 1 Month to < 16 Years of Age With Epilepsy

NCT03405714 ·Status: COMPLETED ·Phase: PHASE2

Trial of Levetiracetam in Patients With Primary Brain Tumors and Symptomatic Seizures Who Undergo Surgery

NCT00571155 ·Status: COMPLETED ·Phase: PHASE4

A Study to Test the Safety/ Efficacy of Brivaracetam (BRV) Used as Adjunctive Treatment in Subjects >=16 Years of Age With Partial Seizures With or Without Secondary Generalization

NCT03250377 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Tolerability of Levetiracetam Add-On Treatment in Refractory Pediatric Patients With Partial Onset Seizures

NCT00615615 ·Status: COMPLETED ·Phase: PHASE3

Safety and Tolerability of Intravenous Brivaracetam (Infusion or Bolus) as Adjunctive Antiepileptic Therapy

NCT01405508 ·Status: COMPLETED ·Phase: PHASE3

Brivaracetam as add-on Treatment in Adolescents and Adults Suffering From Epilepsy

NCT00504881 ·Status: COMPLETED ·Phase: PHASE3

Double-blind, Randomized Study Evaluating the Efficacy and Safety of Brivaracetam in Adults With Partial Onset Seizures

NCT00490035 ·Status: COMPLETED ·Phase: PHASE3

The Effect of Levetiracetam (Keppra) on the Treatment of Tremor in Multiple Sclerosis

NCT00430599 ·Status: COMPLETED

An Open Label Study of L059 (Levetiracetam) in Japanese Epilepsy Subjects With Generalized Tonic-clonic Seizures

NCT01398956 ·Status: COMPLETED ·Phase: PHASE3